Period Ending | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 | Jun 29, 2011 |
---|
Total Revenue
|
1,292,014
|
1,326,710
|
1,309,934
|
1,208,648
| Cost of Revenue | 133,197 | 139,637 | 123,527 | 100,503 | |
Gross Profit
|
1,158,817
|
1,187,073
|
1,186,407
|
1,108,145
| |
|
Operating Expenses |
|
Research Development | 355,962 | 338,934 | 301,391 | 285,644 |
|
Selling General and Administrative | 387,241 | 387,533 | 345,373 | 356,553 |
|
Non Recurring | 283 | 636 | 1,803 |
-
|
|
Others | 45,961 | 50,867 | 49,347 | 55,136 |
|
|
|
Total Operating Expenses | 789,447 | 777,970 | 697,914 |
-
| | |
Operating Income or Loss
|
369,370
|
409,103
|
488,493
|
410,812
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 15,144 | (3,973) | (7,727) | (11,728) |
|
Earnings Before Interest And Taxes | 384,514 | 405,130 | 480,766 | 399,084 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 384,514 | 405,130 | 480,766 | 399,084 |
|
Income Tax Expense | 82,148 | 104,920 | 127,104 | 95,036 |
|
Minority Interest | 295 | 28 | (1,836) | (16,015) |
|
|
|
Net Income From Continuing Ops | 302,661 | 300,238 | 351,826 | 288,033 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
302,661
|
300,238
|
351,826
|
288,033
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
302,661
|
300,238
|
351,826
|
288,033
|
|